Recap

Oral Patient-Controlled-Analgesia (PCA) Device for Seattle Children's Hospital
Project Overview
Recap was developed with the support and guidance of one anaesthesiology attending and two residents at the Seattle Children's Hospital for a "Senior Capstone" project at the University of Washington.

Recap is an oral PCA device designed to support and improve mindful post-operative pain management to maximize patient comfort while deterring opioid medication abuse.

This product is protected as a University of Washington CoMotion Invention #48371. All Rights Reserved.
My Contributions
Project Manager for Ideation/Development phase.

Team:
Scott Smith, Jill Aneri Shah, Ostin Kurniawan, Mackenna Lees

The problem space: the opioid crisis

In order to design a useful and user-friendly product, the team conducted extensive research, including reading scientific articles, conducting interviews, and analyzing potential market competitors.

It was only after understanding the process around prescribing medication and the needs of the consumers that we were able to construct a list of design requirements and begin to build our product. The questions we began our research with are as follows:

After surgery, patients begin recovery in the hospital. To manage the pain they might experience, patients mayuse a patient-controlled analgesic (PCA) device to dispense IV analgesics (pain medication) when required.Supplemented by monitoring by hospital staff, PCA devices are able to prevent overdosing on powerfulopioid-based analgesics while allowing the patient autonomy in managing their own pain. However, when senthome, patients are often written a large prescription for opioid-based analgesics. Unlike in the hospital, patientsare left to their own ability to regulate their dosages. These large prescriptions, often for 30–60 pills [1], are rarelymade with malicious intentions. Generous prescriptions are, instead, usually written with the intent of covering

1

What constraints are reasonable for dispensation of opioids at home?

2

What are users of prescription opioids concerned with in relation to their prescription/pain/dosage?

3

What are the foci of existing home solutions? What are their advantages/pitfalls?

Phase 1: understanding PCA and competitors

In order to design a useful and user-friendly product, the team conducted extensive research, including reading scientific articles, conducting interviews, and analyzing potential market competitors.

It was only after understanding the process around prescribing medication and the needs of the consumers that we were able to construct a list of design requirements and begin to build our product. The questions we began our research with are as follows:

In order to design a useful and user-friendly product, the team conducted extensive research, including reading scientific articles, conducting interviews, and analyzing potential market competitors.

It was only after understanding the process around prescribing medication and the needs of the consumers that we were able to construct a list of design requirements and begin to build our product. The questions we began our research with are as follows: